We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-2.07%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$19.3B
AUM Growth
-$803M
Cap. Flow
+$159M
Cap. Flow %
0.82%
Top 10 Hldgs %
30.79%
Holding
732
New
52
Increased
325
Reduced
233
Closed
41

Top Buys

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$78.3M
2
NEE icon
NextEra Energy
NEE
+$57M
3
NVDA icon
NVIDIA
NVDA
+$48M
4
BABA icon
Alibaba
BABA
+$43.4M
5
AAPL icon
Apple
AAPL
+$39M

Top Sells

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$87.5M
2
RVMD icon
Revolution Medicines
RVMD
+$45.5M
3
ABT icon
Abbott
ABT
+$44.5M
4
JPM icon
JPMorgan Chase
JPM
+$44.3M
5
IQV icon
IQVIA
IQV
+$43M

Sector Composition

Rank Sector Weight
1 Technology 32.73%
2 Healthcare 27.11%
3 Financials 9.44%
4 Consumer Discretionary 7.72%
5 Communication Services 7.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVS icon
151
CVS Health
CVS
$141B
$27.7M 0.14%
385,802
XENE icon
152
Xenon Pharmaceuticals
XENE
$6.45B
$27.7M 0.14%
476,494
+59,092
+14% +$2.72M
CAT icon
153
Caterpillar
CAT
$410B
$27.6M 0.14%
38,971
+2,474
+7% +$1.71M
DE icon
154
Deere & Co
DE
$158B
$27.3M 0.14%
48,419
+3,059
+7% +$1.73M
MTD icon
155
Mettler-Toledo International
MTD
$26.2B
$27.1M 0.14%
21,458
-5,978
-22% -$8.06M
AMP icon
156
Ameriprise Financial
AMP
$47.5B
$26.9M 0.14%
60,535
+1,690
+3% +$814K
FTNT icon
157
Fortinet
FTNT
$116B
$26.9M 0.14%
328,975
+34,499
+12% +$2.79M
TNGX icon
158
Tango Therapeutics
TNGX
$4.72B
$26.6M 0.14%
1,269,246
+560,434
+79% +$7.8M
CELC icon
159
Celcuity
CELC
$4.47B
$26.3M 0.14%
230,603
-245,767
-52% -$26.8M
VZ icon
160
Verizon
VZ
$183B
$26.1M 0.14%
520,114
+112,826
+28% +$5.23M
LNG icon
161
Cheniere Energy
LNG
$55B
$26.1M 0.14%
91,933
+65,738
+251% +$15.2M
PGR icon
162
Progressive
PGR
$120B
$25.8M 0.13%
130,199
-110,848
-46% -$22.9M
NKE icon
163
Nike
NKE
$63.7B
$25.7M 0.13%
486,635
+177,652
+57% +$10.8M
ARQT icon
164
Arcutis Biotherapeutics
ARQT
$3.53B
$25.6M 0.13%
1,086,651
+283,513
+35% +$7.24M
VLO icon
165
Valero Energy
VLO
$93.5B
$25M 0.13%
101,094
+60,126
+147% +$12.4M
DFTX
166
Definium Therapeutics
DFTX
$5.98B
$24.4M 0.13%
1,293,629
+322,411
+33% +$5.47M
BRKR icon
167
Bruker
BRKR
$9.2B
$24.4M 0.13%
676,424
+128,821
+24% +$5.39M
TPR icon
168
Tapestry
TPR
$28.7B
$24.4M 0.13%
172,856
-36,623
-17% -$5.19M
CBOE icon
169
Cboe Global Markets
CBOE
$28.7B
$24.3M 0.13%
86,469
-34,208
-28% -$9.52M
MCO icon
170
Moody's
MCO
$85.7B
$24.3M 0.13%
55,674
+28,782
+107% +$13.6M
HLT icon
171
Hilton Worldwide
HLT
$73.7B
$24.1M 0.13%
79,148
-4,841
-6% -$1.47M
PEP icon
172
PepsiCo
PEP
$184B
$23.7M 0.12%
152,430
-23,925
-14% -$3.73M
ELVN icon
173
Enliven Therapeutics
ELVN
$3.88B
$23.3M 0.12%
594,079
+141,060
+31% +$3.91M
ULTA icon
174
Ulta Beauty
ULTA
$21B
$23.2M 0.12%
44,455
-8,424
-16% -$5.36M
IBM icon
175
IBM
IBM
$198B
$23.1M 0.12%
95,331
+18,524
+24% +$5.01M

Similar funds

Candriam SCA's Q1 2026 Portfolio in Review

As of Q1 2026, Candriam SCA held 732 positions worth $19.3B, down 4% from $20.1B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Candriam SCA's Q1 2026 filing shows 52 new, 325 increased, 233 reduced and 41 closed positions. Its largest new stake was Service Corp International: 360,195 shares worth $29.7M. The largest sale was Nu Holdings, an estimated $87.5M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2026 buy was Service Corp International: 360,195 shares worth $29.7M.
  • Candriam SCA added most to KLA in Q1 2026, an estimated $78.3M increase.
  • Candriam SCA's biggest Q1 2026 reduction was Nu Holdings, cutting an estimated $87.5M.
  • Candriam SCA fully exited Banco Macro in Q1 2026, selling an estimated $25.6M.
  • Candriam SCA's ten largest holdings make up 31% of its $19.3B portfolio in Q1 2026.
  • Candriam SCA opened 52 new positions and closed 41 in Q1 2026.
  • Candriam SCA's portfolio value fell 4% quarter-over-quarter to $19.3B.

Based on Candriam SCA's 13F filing for Q1 2026, filed 30 Apr 2026.